The potential therapeutic applications of peptides, including BPC57, are being explored, and if they are moved to a category one list, they may become more widely available by prescription, which could lead to further research and development 10m30s
Peptide program pricing varies depending on peptide selection, supply length, dosing, pharmacy preparation, medication availability, and provider recommendation
These experimental drugs came about to solve real problems
On July 23 and 24, an FDA advisory committee will meet to decide if licensed pharmacies can compound BPC-157, TB-500, KPV, MOTS-c, DSIP, Semax, and Epitalon for patients with a prescription
Or are there pharmaceutical companies trying to capture these peptide products and capitalize the hell out of them